Foluso Agboola discusses the Institute for Clinical and Economic Review's newest analysis, which has found that most new ...

A new digital health tool increased rates of lung cancer screening, according to research published Oct. 20 in JAMA. Investigators from Wake Forest University School of Medicine, ...

Although it’s commonly recommended to test for albuminuria in people with diabetes or high blood pressure, testing is often ...

The oral microbiome is home to more than 700 species of bacteria, and the average person hosts approximately 250 species at a time, according to the study. Each person’s oral microbiome is unique and ...

Data analyses from two real-world trials of Rebyota (fecal microbiota, live-jslm)efficacy and safety will be presented at IDWeek 2025, according to the details of a recent Ferring Pharmaceuticals news ...

Patients with Type 1 diabetes are often excluded from diabetes and weight loss trials. Forty years ago, the vast majority of patients with Type 1 diabetes didn’t need help with the problem of being ...

These gaps stem from systemic barriers, including limited access to early detection, follow-up delays and inequities in ...

Tzield, a monoclonal antibody approved for stage 2 Type 1 diabetes, now seeks approval for stage 3 disease based on trial ...

Based on data including more than 788 million patient visits from more than 15,000 ophthalmologists, thousands of eyes were ...

However, ongoing studies, including perianal fistulizing disease trials and the REASON study evaluating transmural healing, will address some of these knowledge gaps in the future. For patients, the ...

An expert discusses how underutilization of combination lipid-lowering therapies stems from overly complex guidelines, primary care providers managing multiple chronic diseases simultaneously, cost ...

Kenneth A. Beckman, M.D., doesn’t see insurers as standing in the way of patients getting treated with the “epi-on” approach ...